Liver fibrosis: non-invasive assessment with MR elastography

Area of Science:

• Medical Imaging
• Hepatology
• Biophysics

Background:

• Liver biopsy is the gold standard for staging liver fibrosis but is invasive.
• Chronic liver disease staging is crucial for patient management and treatment decisions.
• Non-invasive methods are needed to accurately assess liver fibrosis non-invasively.

Purpose of the Study:

• To evaluate the feasibility of Magnetic Resonance (MR) elastography for non-invasive liver fibrosis staging.
• To correlate MR elastography findings with liver biopsy results.
• To assess the diagnostic performance of MR elastography in differentiating fibrosis stages.

Main Methods:

• Twenty-five patients with suspected chronic liver disease underwent MR elastography and liver biopsy.
• Liver biopsy samples were staged using the METAVIR scoring system (F0-F4).
• MR elastography involved applying mechanical waves to the liver and processing phase maps to derive shear elasticity and viscosity.

Main Results:

• Hepatic shear elasticity significantly increased with advanced fibrosis stages (F0-F1: 2.24 kPa, F2-F3: 2.56 kPa, F4: 4.68 kPa).
• Shear viscosity was significantly higher in cirrhotic patients (F4: 5.19 Pa x s) compared to those without cirrhosis (F0-F1: 2.39 Pa x s, F2-F3: 2.27 Pa x s).
• Statistical analysis confirmed significant differences between fibrosis groups (p < 0.05).

Conclusions:

• Non-invasive MR elastography is a feasible method for assessing liver fibrosis stage.
• MR elastography can differentiate between various stages of liver fibrosis, including cirrhosis.
• This technique offers a promising non-invasive alternative to liver biopsy for fibrosis assessment.